Bendamustine–rituximab (BR) combined therapy for treatment of immuno-mediated neuropathies associated with hematologic malignancy
Federico Massa, Angela Zuppa, Giampaola Pesce, Chiara Demichelis, Micaela Bergamaschi, Martina Garnero, Chiara Briani, Sérgio Ferrari, Angelo Schenone, Luana Benedetti
Topics & Concepts
MedicineRituximabBendamustineInternal medicineMalignancyRegimenMacroglobulinemiaChronic inflammatory demyelinating polyneuropathyPolyradiculoneuropathyGastroenterologyOncologySurgeryImmunologyAntibodyLymphomaMultiple myelomaGuillain-Barre syndromePeripheral Neuropathies and DisordersMultiple Myeloma Research and TreatmentsChronic Lymphocytic Leukemia Research